NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Short Interest Update

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the target of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 18,100 shares, a decline of 24.9% from the November 15th total of 24,100 shares. Based on an average daily volume of 16,100 shares, the short-interest ratio is currently 1.1 days.

NLS Pharmaceutics Price Performance

NASDAQ NLSPW remained flat at $0.01 during trading on Friday. The company’s stock had a trading volume of 51,028 shares, compared to its average volume of 18,465. NLS Pharmaceutics has a 52 week low of $0.01 and a 52 week high of $0.10. The business’s 50 day moving average is $0.01 and its 200 day moving average is $0.02.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).